




No evidence for increased self-reported cognitive failure in Type 1 and Type 2 diabetes
Wessels, A.M.; Pouwer, F.; Geelhoed-Duijvestijn, P.H.; Snel, M.; Kostense, P.J.; Scheltens,
P.; Heine, R.J.; Snoek, F.J.
Published in:
Diabetic Medicine: Journal of Diabetes UK
Publication date:
2007
Link to publication in Tilburg University Research Portal
Citation for published version (APA):
Wessels, A. M., Pouwer, F., Geelhoed-Duijvestijn, P. H., Snel, M., Kostense, P. J., Scheltens, P., Heine, R. J., &
Snoek, F. J. (2007). No evidence for increased self-reported cognitive failure in Type 1 and Type 2 diabetes: A
cross-sectional study. Diabetic Medicine: Journal of Diabetes UK, 24(7), 735-740.
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 12. May. 2021
 
© 2007 The Authors.



















Diabetes mellitus is associated with the occurrence of well-
described microvascular and macrovascular complications,
including retinopathy, nephropathy, peripheral neuropathy and
cardiovascular disease. Evidence is increasing that diabetes is
also associated with mild performance deficits on a range of
neuropsychological tests [1,2].
Little is known, however, about the subjective experience of
cognitive dysfunctioning in persons with diabetes. Subjective
cognitive complaints may include decreased attention and con-
centration, forgetfulness, difficulty completing more than one
task simultaneously, and slowed thinking [3,4]. It is important
to note that from a quality of life perspective, the subjective
experience of cognitive dysfunction is an important outcome
in itself [5–7]. Moreover, reported cognitive complaints may
have prognostic value, as they could be early signs of cognitive
decline in the future, as has been shown in dementia [8–11].
To the best of our knowledge, the question of whether
middle-aged adult patients with Type 1 and Type 2 diabetes
have subjective complaints has not yet been studied. Subjective
cognitive complaints in diabetes may be influenced by age,
education and diabetes-related factors, including duration of
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Mild cognitive deficits have been determined in both types of diabetes using neurocognitive tests. Little is known
about the degree to which patients complain about their cognitive functioning. This study set out to investigate the magnitude




Subjective cognitive functioning was measured in 187 diabetic patients using the Cognitive Failures Questionnaire
(CFQ). Demographic and clinical characteristics were retrieved from the medical records. The Patient Health Questionnaire 9




Analyses were based on 55 patients with Type 1 diabetes and 100 patients with Type 2 diabetes. No difference in
mean CFQ score was observed between Type 1 and Type 2 diabetic patients or between Type 1 diabetic patients and
healthy control subjects. Female patients with Type 2 diabetes reported significantly fewer cognitive complaints compared
with female healthy control subjects. None of the demographic variables and diabetes-related complications was asso-
ciated with subjective cognitive complaints. A strong positive association was found between depression symptomatology




Our study could not confirm elevated subjective cognitive complaints in a group of Type 1 and Type 2 diabetes
patients, as might be expected given the observed elevated rates of mild cognitive dysfunction in patients with diabetes.
Self-reported cognitive failure appears largely determined by depressive symptomatology. Therefore, affective status should
be included in any cognitive assessment procedure.








CFQ, Cognitive Failures Questionnaire; PHQ-9, Patient Health Questionnaire 9 items
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complications. Also, depressed mood can influence subjective
cognitive functioning and should therefore be taken into account
[6,12–16].
The aim of this study was to investigate (i) the magnitude of
cognitive complaints in adult patients with Type 1 and Type 2
diabetes relative to published norms for healthy control
subjects, and (ii) the associations between these complaints
and demographic and clinical patient characteristics, including






Data were collected within the framework of a multicentre
depression screening research project in the Netherlands. For the
present study, baseline data from one of the participating
hospitals, Haaglanden Medical Centre (Westeinde, The Hague,
the Netherlands) were used. A random sample of 555 out-patients
with diabetes was drawn from the patient register of Westeinde
Hospital. A demographic questionnaire (including a question
regarding total number of severe hypoglycaemic episodes), a
second questionnaire (depression and cognitive failures; see
Measures) and, in case of non-response, a reminder letter (which
was sent after the first letter and questionnaires) were sent to
these out-patients. Clinical information was extracted from the
medical records of each patient. Patients were excluded on the
grounds of epilepsy, stroke or if taking psychiatric medication at
that time.
Written consent was obtained from all participants and the
study was approved by the local medical ethics advisory com-
mittee. The investigations were carried out in accordance with




Participants completed the following questionnaires at home
and returned the completed questionnaires in stamped ad-
dressed envelopes:
1. A short questionnaire was developed with questions pertain-
ing to history of head trauma, Parkinson’s disease, epilepsy, blood
pressure, stroke, psychotropic medication and history of severe
hypoglycaemia since disease onset (defined as hypoglycaemia
with unconsciousness and external assistance for recovery since
diabetes onset).
2. The Dutch version of the Cognitive Failures Questionnaire
(CFQ) [17,18]. The CFQ consists of 25 items measuring the
frequency of everyday cognitive failures or lapses in the general
population. These concern failures of memory, attention, motor
function and perception. Evidence suggests the CFQ is unifac-
torial, measuring a general factor of cognitive failure [17–20].
Each item is rated for frequency in the past 6 months, from 4
(‘very often’) to 0 (‘never’). The maximum score is 100. Higher
total CFQ scores reflect a higher frequency of self-reported cog-
nitive failures. The psychometric qualities of the Dutch translation









 of a Dutch reference





3. We used the nine-item depression module of the Patient
Health Questionnaire, the PHQ-9, to chart the frequency of de-
pression symptoms occurring during the previous 2 weeks [22].
A PHQ diagnosis of major depression has been found to have
high agreement with the diagnosis of major depression based




4 indicate no de-
pression. Scores of 5–14 indicate a need for clinical judgement
about treatment, based on the patient’s duration of symptoms




 15 represent likely
major depression.
From the medical records of the patients, the following data
were extracted: age, gender, ethnicity (White or non-White),
highest level of completed educational level [this variable was
assessed by a Dutch scoring system that consists of an eight-point
scale, ranging from unfinished primary education (level 1) to
university education (level 8)], type of diabetes, duration of dia-
betes, microvascular complications (retinopathy: background













Statistical analysis was performed using SPSS version 11.0 (SPSS
Inc., Chicago, IL, USA). Continuous demographic data of the










 tests were used for categorical variables [for expected fre-





< 0.05 was considered to be statistically significant. Stepwise
linear multiple regression analysis (both groups of diabetes in
one regression model) was used to study whether subjective
cognitive complaints could be predicted by means of three sub-
sequent blocks, that contained the following independent vari-
ables (coded as 1 for the regression analysis): (i) female gender,
age, being married/partner, having low education [which is de-
fined as equal to or less than vocational training (level 3 accord-
ing to the Dutch scoring system)], non-White; (ii) diabetes
duration, retinopathy (background and proliferative retinopathy
combined), nephropathy, neuropathy, cardiovascular disease(s)
and severe hypoglycaemic episodes (defined as hypoglycaemia
with unconsciousness and external assistance for recovery since
diabetes onset); and (iii) depression score.
First, we investigated the contribution of the demographic
variables on CFQ scores (Model 1). Those variables which were
not significantly predictive of CFQ scores were removed from
the second step (Model 2): the contribution of the clinical variables
on CFQ score. In the last step (Model 3, prediction of depression
scores on CFQ scores) only those variables significantly pre-
dicting CFQ scores in any of the earlier models were included.
Age and gender were included in all of the models. Analyses
were based on all participants for whom data were complete.






In total, 272 (of 555) questionnaires were returned (49%); 54
(16%) questionnaires were returned after the reminding letter.
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Of these, 236 participants (43%) gave informed consent and
returned a completed first screening questionnaire (demo-
graphic variables); 18 (3%) had died; 12 (2%) responded that
they refused to participate because of lack of time or interest;
three (1%) responded that they were too ill or incapacitated to
participate and another three (1%) had moved. The remaining
283 (51%) did not respond. Due to non-response to the second
questionnaires containing the depression measure and the CFQ,
a further 49 participants were lost, leaving a study sample of
187 participants.
Type of diabetes was known for 166 of the 187 patients. There
were 57 (34%) patients with Type 1 diabetes and 109 (66%) with
Type 2 diabetes. Two participants reported having epilepsy,
five had a history of stroke, one patient had both a history of
stroke and epilepsy and three patients used medication to treat
psychiatric comorbidity/disease. These patients were excluded
from analysis. Therefore, analyses were based on 55 patients
with Type 1 diabetes and 100 with Type 2 diabetes (Table 1).
Patients with Type 2 diabetes were significantly older (59.0 vs.
42.8 years), had lower education (41.1% vs. 17.3% were educated
to vocational training or less: level 3), had a shorter diabetes
duration (15.4 vs. 23.8 years), had more disease-related compli-
cations, experienced fewer hypoglycaemic episodes since diabe-
tes onset (1.2 vs. 4.2 episodes), were less often married/or with




There was no significant difference in mean CFQ score between




 13.7) and patients with








 0.14). However, in the Type
1 diabetes patient group, females reported significantly more














There was no significant difference in total number of
self-reported cognitive failures between patients with Type 1












 = 0.84). Patients with Type 2 diabetes reported significantly














No differences in self-reported cognitive failures were found







































 = 0.60 for women). We did not find a
difference in self-reported cognitive failures in male Type 2













 = 0.37). However, female patients with
Type 2 diabetes reported significantly fewer cognitive failures














Table 1 Clinical characteristics of the study population
Type 1 diabetes Type 2 diabetes 
Male Female Total Male Female Total
N 20 35 55 46 54 100
Age (years) 39.5 ± 10.2 44.4 ± 13.5 42.8 ± 12.6 57.5 ± 11.5 60.3 ± 12.8 59.0 ± 12.2***
Married/partner 80.0% (16/20) 81.3% (26/32) 80.8% (42/52) 78.3% (36/46) 50.0% (25/50)† 63.5% (61/96)*
Non-White 5.3% (1/19) 9.7% (3/31) 8.0% (4/50) 37.2% (16/43) 35.4% (17/48) 36.3% (33/91)***
Low education 15% (3/20) 18.8% (6/32) 17.3% (9/52) 34.1% (15/44) 47.1% (24/51) 41.1% (39/95)**
HbA1c (%) 7.7 ± 1.0 
(n = 17)
7.9 ± 1.2 
(n = 29)
7.9 ± 1.1 
(n = 46)
8.0 ± 1.5 
(n = 40)
8.3 ± 1.7 
(n = 43)
8.2 ± 1.6 
(n = 83)
Diabetes duration (years) 21.0 ± 9.6 25.2 ± 12.7 23.8 ± 11.8 16.5 ± 8.3 14.4 ± 8.9 15.4 ± 8.6***
No retinopathy 76.5% (13/17) 75.0% (24/32) 75.5% (37/49) 68.3% (28/41) 70.8% (34/48) 69.7% (62/89)
Background retinopathy 17.6% (3/17) 9.4% (3/32) 12.2% (6/49) 24.4% (10/41) 20.8% (10/48) 22.5% (20/89)
Proliferative retinopathy 5.9% (1/17) 15.6% (5/32) 12.2% (6/49) 7.3% (3/41) 8.3% (4/48) 7.0% (7/89)
Neuropathy 17.6% (3/17) 3.1% (1/32) 8.2% (4/49) 25.0% (10/40) 24.5% (12/49) 24.7% (22/89)*
Nephropathy 16.7% (3/18) 6.3% (2/32) 10.0% (5/50) 27.9% (12/43) 14.0% (7/50) 20.4% (19/93)
Cardiovascular disease 5.9% (1/17) 20.0% (6/30) 14.7% (7/47) 50.0% (20/40) 24.4% (11/45)† 36.5% (31/85)**
Severe hypoglycaemic episodes 3.68 ± 6.25 
(n = 19)
4.52 ± 6.78 
(n = 31)
4.20 ± 6.53 
(n = 50)
1.83 ± 5.41 
(n = 36)





Systolic 126.0 ± 10.8 128.5 ± 12.0 128.0 ± 11.5 141.3 ± 17.5 135.8 ± 14.9 138.6 ± 16.4
(n = 5) (n = 17) (n = 22) (n = 27) (n = 26) (n = 53)**
Diastolic 75.0 ± 5.0 74.1 ± 8.0 74.3 ± 7.3 80.0 ± 9.9 77.8 ± 8.0 78.9 ± 9.0*
Use antihypertensive agents 7.1% (1/14) 16.0% (4/25) 12.8% (5/39) 71.1% (27/38) 48.8% (21/43)† 59.3% (48/81)***
*P < 0.05; **P < 0.01; ***P < 0.001 comparing all Type 1 diabetic patients with all Type 2 diabetic patients.
†P < 0.05 comparing men and women within the Type 2 diabetes group.
Low education is defined as vocational training or less (level 3 according to the Dutch scoring system). Severe hypoglycaemic episodes is defined 
as total number of hypoglycaemic episodes with unconsciousness and external assistance for recovery required since diabetes onset. Missing data 
are the result of missing data in the medical records.
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The mean PHQ-9 score was not significantly different between













 = 0.33). In both types of diabetes, females














Four Type 1 diabetic patients (7.5%; one male, three female)





depression, whereas 11 patients (11.1%; three male, eight





3.4). There was no significant association between
















Correlates of subjective cognitive complaints
 
In view of the small sample sizes, we performed stepwise
multiple regression analyses in the total patient group (Table 2).




 = 135), it appeared that none of the demo-
graphic variables was significantly associated with the frequency





 = 108), also adjusted for age and gender], none of the
diabetes-related complications (diabetes duration, retinopathy,
nephropathy, neuropathy, severe hypoglycaemic episodes and
cardiovascular disease) was associated with subjective cogni-




 = 152, also adjusted for age and
female gender), total PHQ-9 score accounted for 33% of the
explained variance and all predictors in Model 3 explained
35% of the variance in CFQ scores. If the effects of age and
gender were held constant, there was a strong positive associ-
ation between total PHQ-9 scores and cognitive failures.
Exclusion of participants with a PHQ-9 score of > 15 (severe
depression) did not affect the results.
The finding that female patients had significantly higher
scores on the PHQ-9 prompted us to explore an interaction
effect of gender and PHQ-9 scores on cognitive failures. We




 PHQ-9 score into Model 3 of the






















indicating that the positive association between depression and
cognitive failures, as was shown from the regression analysis,
was similar for men and women.
Furthermore, it also appeared that there was no significant


























 = 0.28), indicating that the
positive association between depression and cognitive failures




The central finding of this study is that patients with Type 1
and Type 2 diabetes appear not to complain more about their
cognitive functioning than a healthy reference group. Further-
more, no differences in number of self-reported cognitive fail-
ures were found between Type 1 and Type 2 diabetic patients.
Interestingly, diabetes-related factors, including complication
status and frequency of severe hypoglycaemia, did not predict
subjective cognitive functioning. However, a strong positive
association was found between depression symptomatology
and frequency of self-reported cognitive failures. Overall, our
study could not confirm more subjective cognitive complaints
in a group of Type 1 and Type 2 diabetic patients as might be
expected given the observed elevated rates of mild cognitive
dysfunction in patients with diabetes [1,2].
The participants’ subjective cognitive complaints, although
important in their own right, probably do not provide a relia-
ble measure of their objective cognitive performance. Indeed,
the clinical utility of subjective cognitive complaints as indica-
tors of cerebral dysfunction has not been clearly established.
Some studies have found a relationship between subjective and
objective measures of cognitive impairment [24–26], whereas
others, which studied patients with cancer, temporal lobe
epilepsy, multiple sclerosis and older persons, failed to find such
a relationship [5,6,12,13,27–29]. The question therefore arises
whether complaints about memory and attention in patients
with diabetes have a prospective value, as is the case in, for
example, dementia. A longitudinal study that included a
substantial number of participants with borderline cognitive
impairment, as well as participants without memory complaints,
has found that baseline memory complaints have significant
FIGURE 1 Mean CFQ scores for patients and healthy control subjects 
[Dutch reference group (3021 healthy adults)]. CFQ, Cognitive Failures 
Questionnaire. , Male; , female.
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predictive value for dementia at 3 years [8]. Memory com-
plaints were associated with future cognitive decline in parti-
cipants with baseline cognitive impairment and in participants
whose cognition was in the normal range at baseline [9,10].
Finally, a review article [11] concluded that there is an established
association between memory complaints and decline in mem-
ory (or dementia) in older participants. Clearly, prospective
studies into the relationship between objective cognitive
performance and subjective cognitive complaints in larger
populations of patients with Type 1 and Type 2 diabetes are
warranted. Meanwhile, self-reported complaints of cognitive
function appear to be of limited clinical use and should there-
fore be interpreted with caution.
The finding that subjective cognitive functioning was closely
related to depressive affect is not unexpected. Others have
also found such a relationship [6,12–16]. Maor et al. [13], for
example, found a high correlation between perceived cognitive
deficits and depressive symptoms in multiple sclerosis patients.
Cull and colleagues [6] studied a group of adult patients after
treatment for lymphoma and found that there was no difference
between ‘complainers’ and ‘non-complainers’ in their perfor-
mance on standard neuropsychometric tests of concentration
and memory. Again, those reporting concentration and mem-
ory difficulties had significantly higher scores on measures of
anxiety, depression and fatigue. The importance of addressing
depression in diabetes is underscored by the fact that diabetes
has been reported to at least double the risk of comorbid
depression, with the point prevalence approximating 11% in the
diabetic population [30–32]. Depression should therefore be
part of any comprehensive neuropsychological examination.
There are some limitations to this study. First, the relatively
high rate of non-responders (51%) limits the generalizability.
Second, we may wonder if the CFQ is suitable to detect the
mild cognitive impairment observed in persons with diabetes.
The CFQ provides a reliable general measure of perceived
cognitive failure that includes perception, memory and motor
function, but does not possess any additional factors [17–20].
It would be of interest to elucidate separate cognitive domains,
known to be affected by diabetes, and to study whether diabetic
patients have cognitive complaints related to these specific
domains. As far as we know, such a measure does not yet exist.
We conclude that mean CFQ scores of patients with Type 1
and Type 2 diabetes are similar to those found in the general
population. Whether the failure to demonstrate higher rates
of subjective cognitive failure in this group is due to a lack of
sensitivity of the measure used to detect cognitive impairment
Table 2 Stepwise multiple regression analysis predicting cognitive failures (CFQ) by demographic variables, complications of diabetes and depression
Model 1 (N = 135)
DM1 = 49, DM2 = 86
Model 2 (N = 108)
DM1 = 43, DM2 = 65
Model 3 (N = 152) 
DM1 = 53, DM2 = 99 
Demographic variables only
Clinical characteristics 




B SE B β P B SE B β P B SE B β P
A. Demographic variables
Age −0.12 0.11 −0.10 0.30 −0.15 0.12 −0.14 0.22 −0.12 0.08 −0.10 0.14
Female gender 1.90 3.01 0.06 0.53 2.00 3.05 0.06 0.51 −1.82 2.35 −0.05 0.44
Married/partner 2.95 3.38 0.08 0.38
Low education −1.58 3.37 −0.04 0.64
Non-White 1.35 3.41 0.04 0.69
B. Clinical characteristics
Diabetes duration 0.16 0.15 0.11 0.31
Cardiovascular disease −1.47 4.02 −0.04 0.72
Retinopathy (background and 2.63 3.57 −0.08 0.46
proliferative combined)
Nephropathy −6.60 4.61 −1.14 0.16
Neuropathy −2.10 4.29 −0.05 0.63
Severe hypoglycaemic episodes 0.40 0.30 0.14 0.18
C. Depression
PHQ-9 1.84 0.21 0.59 < 0.001
R2 0.03 0.12 0.35
R2 change 0.03 0.07 0.33
F change 0.71 1.27 75.33
P 0.62 0.14 < 0.001
Retinopathy is defined as background retinopathy and proliferative retinopathy combined. Low education is defined as vocational training or 
less (level 3).
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remains to be seen. Self-reported cognitive failures appear
largely determined by depression. Future research should include
measures of objective neuropsychological performance to be
able to distinguish subjective from objective cognitive dysfunc-
tion. Furthermore, little is known about the subjective experi-
ence of cognitive dysfunction in persons with diabetes and
how this affects their daily functioning and diabetes self-
management. This is also an interesting future research topic.
Finally, our findings stress the importance of including affective
status in any cognitive assessment procedure. Neuropsycho-
logical examination is the gold standard, but assessing individuals’
perceived cognitive performance is an important source of
information in its own right. Future research will show if sub-
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